VasDeBlock medical ApS: Financial statements 2024
CVR: 37525758
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
VasDeBlock medical ApS (CVR 37525758) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -76,324 and a net result of DKK -76,186 compared with DKK -56,179 the year before. Equity in the 2024 report amounted to DKK -5,926.
- Revenue
- DKK 0
- Gross Profit
- DKK -76,324
- Profit/Loss
- DKK -76,186
- Equity
- DKK -5,926
- Total Assets
- DKK 68,266
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 0 | -76K | -76K | -6K | - |
| 2023 | 60K | -56K | -56K | 70K | - |
| 2022 | 0 | -97K | -112K | 32K | - |
| 2021 | 0 | -68K | -83K | 51K | - |
| 2020 | 0 | -247K | -263K | 74K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
VasDeBlock medical ApS has published its annual report for 2023. Revenue came to DKK 60,000, and the net result was DKK -56,179.
About VasDeBlock medical ApS
VasDeBlock medical ApS is a Danish company of the type Anpartsselskab based in Karise, founded in 2016. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mette Mikkelsen. The board consists of Nickolei Henrik Nagel (chair), Anders Brummerstedt-Madsen, Henrik Harboe and Niels Bøggild Lindeburg. The company's owners include Mette Mikkelsen, Nickolei Henrik Nagel and HOLDINGSELSKABET TEG AF 2011 ApS. In 2025, the company reported a gross profit of DKK -103,154 and a net result of DKK -103,099 compared with DKK -76,186 the year before. Equity in the 2025 report amounted to DKK 79,417.